OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Novozymes A/S/  DK0060336014  /

Quotrix
29/05/2024  07:57:07 Chg. -1.5200 Volume Bid19:01:20 Ask19:01:20 Market Capitalization Dividend Y. P/E Ratio
56.5400EUR -2.62% -
Turnover: -		 55.5200Bid Size: 100 55.8200Ask Size: 100 15.46 bill.EUR - -
GlobeNewswire 07/05 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 07/05 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 03/05 Q1 update: Novonesis delivers 4% organic sales growth in line with expectations and reports progress...
GlobeNewswire 01/02 Legacy Novozymes delivers solid last full-year results
GlobeNewswire 29/01 The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a l...
GlobeNewswire 13/12/2023 Novozymes and Chr. Hansen announce name of future combined company; Novonesis
GlobeNewswire 09/11/2023 Novozymes launches Quara® LowP for renewable diesel feedstock pre-treatment
GlobeNewswire 08/11/2023 Michael Burns Joins Invizyne as Executive Vice President of Energy Transition
GlobeNewswire 26/10/2023 Novozymes accelerates growth in Q3 and is on track to deliver on full-year expectations
GlobeNewswire 28/09/2023 Novozymes launches new biosolution to redefine the plant-based meat experience by enhancing texture ...
GlobeNewswire 21/09/2023 Gurnet Point Capital and Novo Holdings A/S Complete Acquisition of Paratek Pharmaceuticals, Inc.
GlobeNewswire 04/09/2023 Novozymes and Bactolife join forces to significantly reduce post weaning diarrhea and antibiotic use...
Newsfile Corp 31/05/2022 Industry Leader Novozymes OneHealth's White Paper on Helicobacter Pylori Research was Officially Rel...
GlobeNewswire 15/02/2022 NMD Pharma Raises €35 Million in a new Financing
GlobeNewswire 15/02/2022 NMD Pharma Raises €35 Million in a new Financing
GlobeNewswire 01/02/2022 Novozymes delivers strong 2021 full-year results and expects continued, solid progress in 2022
GlobeNewswire 20/12/2021 CENTOGENE Announces CEO to Take Temporary Medical Leave of Absence – Biopharmaceutical Industry Vete...
GlobeNewswire 16/12/2021 Marrone Bio Optimizes Bioherbicide with New Bacteria Strains, Accelerates Product Development to Ent...
GlobeNewswire 16/12/2021 Closing the gap between sustainability and profits in corn wet milling
GlobeNewswire 15/12/2021 ARTIS Ventures Promotes Ameena El-Bibany to Partner
GlobeNewswire 13/12/2021 Novozymes and Saipem enter collaboration agreement to create a more sustainable CO2 capture
GlobeNewswire 30/11/2021 Novozymes strengthens and accelerates its BioHealth-business by acquiring a majority stake in Synerg...
GlobeNewswire 26/10/2021 Novozymes is unlocking growth by delivering strong Q3 results and increasing full-year guidance
GlobeNewswire 05/10/2021 Novozymes and Anuvia Plant Nutrients Join Forces To Bring Sustainable Bio-Based Nutrients to Commerc...
GlobeNewswire 27/09/2021 Novozymes is unlocking growth with the ambition of doubling company revenue by 2030